Breaking News

Evotec to Build Second Biologics Mfg. Facility in Toulouse

Evotec's first commercial biomanufacturing facility in Europe is anticipated to deliver much needed capacity for biotherapeutic development and manufacturing.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Evotec SE has initiated construction of its J.POD(R) 2 EU biologics manufacturing facility at its Campus Curie in Toulouse, France. Evotec’s second innovative cGMP biomanufacturing facility will employ Just – Evotec Biologics’ technology that utilizes small, automated, highly intensified and continuous bioprocessing operations housed inside autonomous cleanrooms.   J.POD(R) 2 EU will be Evotec’s first commercial biomanufacturing facility in Europe and is anticipated to ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters